Chemogenomic profiling of Plasmodium falciparum as a tool to aid antimalarial drug discovery

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Pradhan, Anupam ^a,e   Siwo, Geoffrey H ^b,c   Singh, Naresh ^a   Martens, Brian ^a   Balu, Bharath ^a,d   Button Simons, Katrina A ^b   Tan, Asako ^b   Zhang, Min ^a   Udenze, Kenneth O ^a   Jiang, Rays H Y ^a   Ferdig, Michael T ^b   Adams, John H ^a   Kyle, Dennis E ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF NOTRE DAME   (United States)

^c IBM T J WATSON RESEARCH CENTER   (United States)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

^e QUEENSBOROUGH COMMUNITY COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; PROTOZOAL PROTEIN;

DRUG DEVELOPMENT; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; MULTIDRUG RESISTANCE; PLASMODIUM FALCIPARUM; PROCEDURES;

ANTIMALARIALS; DRUG DISCOVERY; DRUG RESISTANCE, MULTIPLE; MUTAGENESIS, INSERTIONAL; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS;

EID: 84946750454     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep15930     Document Type: Article

References (39)

1. Ariey, F. et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature 505, 50-55, doi: 10.1038/nature12876 (2014).
2. Ashley, E. A. et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. The New England journal of medicine 371, 411-423, doi: 10.1056/NEJMoa1314981 (2014).
3. Bonnet, M. et al. Varying efficacy of artesunate+ amodiaquine and artesunate+ sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in the Democratic Republic of Congo: a report of two in-vivo studies. Malar J 8, 192, doi: 10.1186/1475-2875-8-192 (2009).
4. Dondorp, A. M. et al. Artemisinin resistance in Plasmodium falciparum malaria. The New England journal of medicine 361, 455-467, doi: 10.1056/NEJMoa0808859 (2009).
5. Mayer, T. U. et al. Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen. Science 286, 971-974 (1999).
6. Yamanishi, Y., Kotera, M., Kanehisa, M., Goto, S. Drug-target interaction prediction from chemical, genomic and pharmacological data in an integrated framework. Bioinformatics 26, i246-254, doi: 10.1093/bioinformatics/btq176 (2010).
7. Baniecki, M. L., Wirth, D. F., Clardy, J. High-throughput Plasmodium falciparum growth assay for malaria drug discovery. Antimicrob Agents Chemother 51, 716-723, doi: 10.1128/AAC.01144-06 (2007).
8. Weisman, J. L. et al. Searching for new antimalarial therapeutics amongst known drugs. Chem Biol Drug Des 67, 409-416, doi: 10.1111/j.1747-0285.2006.00391.x (2006).
9. Yuan, J. et al. Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets. Science 333, 724-729, doi: 10.1126/science.1205216 (2011).
10. Rottmann, M. et al. Spiroindolones, a potent compound class for the treatment of malaria. Science 329, 1175-1180, doi: 10.1126/science.1193225 (2010).
11. Dahl, E. L. et al. Tetracyclines specifically target the apicoplast of the malaria parasite Plasmodium falciparum. Antimicrob Agents Chemother 50, 3124-3131, doi: 50/9/3124 [pii] 10.1128/AAC.00394-06 (2006).
12. Gunasekera, A. M., Myrick, A., Le Roch, K., Winzeler, E., Wirth, D. F. Plasmodium falciparum: genome wide perturbations in transcript profiles among mixed stage cultures after chloroquine treatment. Exp Parasitol 117, 87-92, doi: 10.1016/j. exppara.2007.03.001 (2007).
13. Gamo, F. J. et al. Thousands of chemical starting points for antimalarial lead identification. Nature 465, 305-310, doi: 10.1038/nature09107 (2010).
14. Guiguemde, W. A. et al. Chemical genetics of Plasmodium falciparum. Nature 465, 311-315, doi: 10.1038/nature09099 (2010).
15. Shoemaker, R. H. The NCI60 human tumour cell line anticancer drug screen. Nature reviews 6, 813-823 (2006).
16. Parsons, A. B. et al. Integration of chemical-genetic and genetic interaction data links bioactive compounds to cellular target pathways. Nat Biotechnol 22, 62-69, doi: 10.1038/nbt919 (2004).
17. Stockwell, B. R. Chemical genetics: ligand-based discovery of gene function. Nat Rev Genet 1, 116-125, doi: 10.1038/35038557 (2000).
18. Cong, F., Cheung, A. K., Huang, S. M. Chemical genetics-based target identification in drug discovery. Annu Rev Pharmacol Toxicol 52, 57-78, doi: 10.1146/annurev-pharmtox-010611-134639 (2012).
19. Brown, J. C. et al. Unraveling the biology of a fungal meningitis pathogen using chemical genetics. Cell 159, 1168-1187, doi: 10.1016/j.cell.2014.10.044 (2014).
20. De Backer, M. D. et al. An antisense-based functional genomics approach for identification of genes critical for growth of Candida albicans. Nat Biotechnol 19, 235-241, doi: 10.1038/85677 (2001).
21. Balu, B. et al. piggyBac is an effective tool for functional analysis of the Plasmodium falciparum genome. BMC Microbiol 9, 83, doi: 10.1186/1471-2180-9-83 (2009).
22. Balu, B., Shoue, D. A., Fraser, M. J. Jr., Adams, J. H. High-efficiency transformation of Plasmodium falciparum by the lepidopteran transposable element piggyBac. Proceedings of the National Academy of Sciences of the United States of America 102, 16391-16396 (2005).
23. Thorneycroft, D., Sherson, S. M., Smith, S. M. Using gene knockouts to investigate plant metabolism. Journal of experimental botany 52, 1593-1601 (2001).
24. Date, S. V., Stoeckert, C. J. Jr. Computational modeling of the Plasmodium falciparum interactome reveals protein function on a genome-wide scale. Genome Res 16, 542-549 (2006).
25. Bell, A., Wernli, B., Franklin, R. M. Roles of peptidyl-prolyl cis-trans isomerase and calcineurin in the mechanisms of antimalarial action of cyclosporin A, FK506, and rapamycin. Biochemical pharmacology 48, 495-503 (1994).
26. Liu, J. et al. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66, 807-815 (1991).
27. Mwai, L. et al. Genome wide adaptations of Plasmodium falciparum in response to lumefantrine selective drug pressure. PLoS One 7, e31623, doi: 10.1371/journal.pone.0031623 (2012).
28. Miotto, O. et al. Genetic architecture of artemisinin-resistant Plasmodium falciparum. Nature genetics 47, 226-234, doi: 10.1038/ng.3189 (2015).
29. Hu, G. et al. Transcriptional profiling of growth perturbations of the human malaria parasite Plasmodium falciparum. Nat Biotechnol 28, 91-98, doi: 10.1038/nbt.1597 (2010).
30. Miotto, O. et al. Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia. Nature genetics 45, 648-655, doi: 10.1038/ng.2624 (2013).
31. Chen, N. et al. Fatty Acid Synthesis and Pyruvate Metabolism Pathways Remain Active in Dihydroartemisinin-Induced Dormant Ring Stages of Plasmodium falciparum. Antimicrob Agents Chemother 58, 4773-4781, doi: 10.1128/AAC.02647-14 (2014).
32. Trager, W., Jensen, J. B. Human malaria parasites in continuous culture. Science 193, 673-675 (1976).
33. Johnson, J. D. et al. Assessment and continued validation of the malaria SYBR green I-based fluorescence assay for use in malaria drug screening. Antimicrob Agents Chemother 51, 1926-1933 (2007).
34. Eisen, M. B., Spellman, P. T., Brown, P. O., Botstein, D. Cluster analysis and display of genome-wide expression patterns. Proceedings of the National Academy of Sciences USA 95, 14863-14868 (1998).
35. Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13, 2498-2504, doi: 10.1101/gr.1239303 (2003).
36. Bader, G. D., Hogue, C. W. An automated method for finding molecular complexes in large protein interaction networks. BMC bioinformatics 4, 2 (2003).
37. Salanti, A. et al. Selective upregulation of a single distinctly structured var gene in chondroitin sulphate A-adhering Plasmodium falciparum involved in pregnancy-associated malaria. Molecular microbiology 49, 179-191 (2003).
38. Battle, A., Jonikas, M. C., Walter, P., Weissman, J. S., Koller, D. Automated identification of pathways from quantitative genetic interaction data. Molecular systems biology 6, 379, doi: 10.1038/msb.2010.27 (2010).
39. Costanzo, M. et al. The genetic landscape of a cell. Science 327, 425-431, doi: 10.1126/science.1180823 (2010).